News
If the FDA approves nipocalimab, the long-term data could form part of J&J’s pitch for the gMG market. The labels for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback